Personal Care
Health
Manufacturing

Johnson & Johnson

$138.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.01%) Today
-$0.14 (-0.10%) After Hours

Why Robinhood?

You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!

About

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Employees
135,100
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
368.74B
Price-Earnings Ratio
25.72
Dividend Yield
2.78
Average Volume
7.33M
High Today
$139.50
Low Today
$138.56
Open Price
$139.45
Volume
1.55M
52 Week High
$148.99
52 Week Low
$118.62

Collections

Personal Care
Health
Manufacturing
Retail
Healthcare
Packaging
US
North America

News

Yahoo Finance11h

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

BOSTON/JERUSALEM (Reuters) - Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

236
Seeking Alpha12h

Oklahoma opioid claims cost Teva $85M

Teva Pharmaceutical (NYSE:TEVA) has agreed to an $85M settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

68
New York Times14h

First Opioid Trial Takes Aim at Johnson & Johnson

Did the people who brought you baby powder and baby shampoo also bring you the opioid crisis? That will be the question before an Oklahoma judge starting Tuesday, as the first civil trial takes off on the long, nationwide runway of trials against prescription opioid manufacturers, distributors and sellers. Oklahoma is squaring off against Johnson & Johnson, the New Jersey-based, family-friendly giant, which produces a fentanyl patch. On Sunday, another defendant in the case, Teva Pharmaceuticals Ltd., the...

1

Earnings

$1.72
$1.85
$1.97
$2.10
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Available Jul 16, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.